1.43

3.38% -0.05

After Hours: 1.42 -0.01 -0.70%

Calidi Biotherapeutics Inc (CLDI)

Overview News Price History Discussions Forecast

Calidi Biotherapeutics Inc stock is traded at $1.43, with a volume of 35,300. It is down -3.38% in the last 24 hours and down -7.14% over the past month. Calidi Biotherapeutics Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer. It engages in advancing a potent allogeneic stem cell capable of carrying an anti-tumor payload for use in multiple oncology indications, including high-grade gliomas and solid tumors. The company's cell-based delivery platforms are designed to protect, amplify, and potentiate oncolytic viruses leading to enhanced efficacy and improved patient safety. Its pipeline of products candidates in the clinic includes NeuroNova that are allogeneic neural stem cells loaded with an oncolytic adenovirus for the treatment of high-grade gliomas; and SuperNova, which are allogeneic adipose-derived mesenchymal stem cells loaded with tumor-selective CAL1 oncolytic vaccinia virus for the treatment of advanced metastatic solid tumors. The company was founded in 2014 and is headquartered in San Diego, California.

Previous Close:

$1.48

Open:

$1.43

24h Volume:

35,300

Relative Volume:

0.20

Market Cap:

$10.25M

Revenue:

Net Income/Loss:

$-23.36M

P/E Ratio:

-1.9408

EPS:

-0.7368

Net Cash Flow:

1W Performance:

+2.14%

1M Performance:

-7.14%

6M Performance:

-65.56%

1Y Performance:

-94.53%

1-Day Range:

$1.4101

$1.48

1-Week Range:

$1.38

$1.5499

52-Week Range:

$1.10

$26.04

Calidi Biotherapeutics Inc Stock (CLDI) Company Profile

Name

Calidi Biotherapeutics Inc

Sector

Healthcare (1132)

Industry

Biotechnology (627)

Phone

(858) 794-9600

Address

4475 Executive Drive, Suite 200, San Diego

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CLDI's Discussions on Twitter

Compare CLDI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CLDI Calidi Biotherapeutics Inc	1.43	10.61M	0	-23.36M	0	-0.7368
VRTX Vertex Pharmaceuticals Inc	433.15	107.98B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	742.00	78.84B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	464.93	60.05B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	915.36	55.10B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	206.60	45.09B	447.02M	-1.18B	-906.14M	-6.1812

Calidi Biotherapeutics Inc Stock (CLDI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-22-23	Initiated	H.C. Wainwright	Buy
Oct-09-23	Initiated	Robert W. Baird	Outperform

Calidi Biotherapeutics Inc Stock (CLDI) Latest News

Dec 02, 2025

Will Calidi Biotherapeutics Inc. stock split increase liquidityShare Buyback & Growth Focused Stock Reports - Newser

Dec 02, 2025

How analysts revise price targets for Calidi Biotherapeutics Inc. stockInsider Buying & Real-Time Market Trend Scan - Newser

Dec 02, 2025

Will Calidi Biotherapeutics Inc. stock outperform small cap peers2025 Historical Comparison & Momentum Based Trading Signals - Newser

Dec 02, 2025

Why retail investors favor Calidi Biotherapeutics Inc. stockMarket Rally & Real-Time Volume Analysis Alerts - Newser

Dec 02, 2025

Will Calidi Biotherapeutics Inc. stock outperform benchmarks2025 Performance Recap & AI Forecast Swing Trade Picks - Newser

Dec 02, 2025

Why Calidi Biotherapeutics Inc. stock stays on top picksPortfolio Risk Report & Fast Gaining Stock Reports - Newser

Dec 02, 2025

Is Calidi Biotherapeutics Inc. stock supported by strong fundamentalsFed Meeting & Risk Managed Investment Entry Signals - Newser

Dec 02, 2025

Nov 28, 2025

Day Trade: Will Calidi Biotherapeutics Inc. stock outperform international peersJuly 2025 Chart Watch & Accurate Intraday Trade Tips - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Is Calidi Biotherapeutics Inc. stock undervalued vs historical averagesEarnings Overview Report & Daily Stock Trend Watchlist - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025